False-positive Elevations in Carcinoembryonic Antigen Levels at a Health Screening Center
1
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Background: Although routine screening of carcinoembryonic antigen (CEA) is not recommended for the early diagnosis of colorectal cancers, CEA levels are frequently measured in practice and during opportunistic health screening programs. We evaluated the frequency of false-positive results according to CEA level at a health screening center. Methods: The medical records of 25,786 participants who underwent a general health check-up and CEA testing at the Seoul National University Hospital Healthcare System Gangnam Center from March 2015 to February 2016 were reviewed. CEA levels were measured using the Architect i2000sr (Abbott Laboratories, USA). The cut-off level for elevated CEA was 5.0 ng/mL. Results: Among 25,786 participants who underwent CEA screening, 597 (2.3%) had CEA levels >5.0 ng/mL. Among 597 participants with elevated CEA levels, 12 (2.0%) had actual malignancies with CEA levels of 8.3–155.3 ng/mL. Diabetes, smoking, chronic obstructive pulmonary disease, and colonic polyps were considered as causes of false elevation. The false-positive rates of CEA according to level were as follows: 5.1–10.0 ng/mL, 99.5%; 10.1–15.0 ng/mL, 87.2%; 15.1–20.0 ng/mL, 100.0%; >20.0 ng/mL, 33.3%. A subsequent decrease in the CEA level after a 1-month follow-up was observed in 47.6% of all cases with elevated CEA levels. Conclusions: False elevation in CEA levels in the range of 5.0–20.0 ng/mL is common in patients who underwent testing at a health screening center. False-positive results above 20.0 ng/mL are less common. These data could provide a guide for the interpretation of elevated CEA level at a health screening center.
Abstract
Background: Although routine screening of carcinoembryonic antigen (CEA) is not recommended for the early diagnosis of colorectal cancers, CEA levels are frequently measured in practice and during opportunistic health screening programs. We evaluated the frequency of false-positive results according to CEA level at a health screening center. Methods: The medical records of 25,786 participants who underwent a general health check-up and CEA testing at the Seoul National University Hospital Healthcare System Gangnam Center from March 2015 to February 2016 were reviewed. CEA levels were measured using the Architect i2000sr (Abbott Laboratories, USA). The cut-off level for elevated CEA was 5.0 ng/mL. Results: Among 25,786 participants who underwent CEA screening, 597 (2.3%) had CEA levels >5.0 ng/mL. Among 597 participants with elevated CEA levels, 12 (2.0%) had actual malignancies with CEA levels of 8.3–155.3 ng/mL. Diabetes, smoking, chronic obstructive pulmonary disease, and colonic polyps were considered as causes of false elevation. The false-positive rates of CEA according to level were as follows: 5.1–10.0 ng/mL, 99.5%; 10.1–15.0 ng/mL, 87.2%; 15.1–20.0 ng/mL, 100.0%; >20.0 ng/mL, 33.3%. A subsequent decrease in the CEA level after a 1-month follow-up was observed in 47.6% of all cases with elevated CEA levels. Conclusions: False elevation in CEA levels in the range of 5.0–20.0 ng/mL is common in patients who underwent testing at a health screening center. False-positive results above 20.0 ng/mL are less common. These data could provide a guide for the interpretation of elevated CEA level at a health screening center.
참고문헌 (17)
- Fenton JJ, "Delivery of cancer screening: how important is the preventive health examination?", Arch Intern Med, 167, pp.580~585 (2007)
- Lee TW, "Health promotion health center project", Public Health Nurs, 24, pp.529~537 (2007)
- Lee JH, "Should a colonoscopy be recommended for healthy individuals with increased carcinoembryonic antigen levels? A case-control study", Dig Dis Sci, 56, pp.2396~2403 (2011)
- Lim YK, "Carcinoembryonic antigen screening: how far should we go?", Singapore Med J, 50, pp.862~865 (2009)
- Sturgeon CM, "Use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers", pp.27~36 (2009), American Association for Clinical Chemistry
- Lee C, "Health and Prevention Enhancement(H-PEACE) : a retrospective, population-based cohort study conducted at the Seoul National University Hospital Gangnam Center, Korea", BMJ Open, 8, pp.e019327~ (2018)
- Litvak A, "False-positive elevations of carcinoembryonic antigen in patients with a history of resected colorectal cancer", J Natl Compr Canc Netw, 12, pp.907~913 (2014)
- Jung YS, "Clinical risk stratification model for advanced colorectal neoplasia in persons with negative fecal immunochemical test results", PLoS One, 13, pp.e0191125~ (2018)
- Sanguinetti CM, "Broncho-alveolar lavage fluid level of carcinoembryonic antigen in the diagnosis of peripheral lung cancer", Monaldi Arch Chest Dis, 50, pp.177~182 (1995)
- Weber TH, "Carcinoembryonic antigen(CEA)in blood in cases of pneumonia", Scand J Infect Dis, 18, pp.547~550 (1986)
- Tong J, "Associations between tumor markers and the risk of colorectal polyp recurrence in Chinese people", Int J Clin Exp Med, 8, pp.6397~6405 (2015)
- Zayed AA, "Serum levels of carcinoembryonic antigen in patients with type 2 diabetes", Endocr Pract, 22, pp.1310~1318 (2016)
- Lu J, "HbA1c is positively associated with serum carcinoembryonic antigen(CEA)in patients with diabetes : A cross-sectional study", Diabetes Ther, 9, pp.209~217 (2018)
- Ohwada A, "Effect of cigarette smoke on the mRNA and protein expression of carcinoembryonic antigen(CEA), a possible chemoattractant for neutrophils in human bronchioloalveolar tissues", Thorax, 50, pp.651~657 (1995)
- Pezzuto A, "Short-term effectiveness of smoking-cessation treatment on respiratory function and CEA level", J Comp Eff Res, 2, pp.335~343 (2013)
- Tong J, "Associations between tumor markers and the risk of colorectal polyp recurrence in Chinese people", Int J Clin Exp Med, 8, pp.6397~6405 (2015)
- 박준홍, "Comparison of Four Automated Carcinoembryonic Antigen Immunoassays: ADVIA Centaur XP, ARCHITECT I2000sr, Elecsys E170, and Unicel Dxi800", Annals of Laboratory Medicine, 38(4), pp.355~361 (2018), 대한진단검사의학회